SCHEMBL102191

SCHEMBL102191

C/C=C/CC(C)C(O)C1C(=O)NC(C)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 14/20 0.89
PPIA P62937 5/20 0.89
FKBP1B P68106 2/20 0.89
ABCC1 P33527 2/20 0.89
ABCC2 Q92887 2/20 0.89
PPP3CA Q08209 2/20 0.89
MEN1 O00255 1/20 0.89
NPC1 O15118 1/20 0.89
ABCC3 O15438 1/20 0.89
GMNN O75496 1/20 0.89
USP2 O75604 1/20 0.89
SLCO2B1 O94956 1/20 0.89
ABCB11 O95342 1/20 0.89
LMNA P02545 1/20 0.89
POLB P06746 1/20 0.89
CYP3A4 P08684 1/20 0.89
MAPT P10636 1/20 0.89
RARB P10826 1/20 0.89
CYP2C9 P11712 1/20 0.89
CYP3A5 P20815 1/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22033395 1.00 ABCB1 (0.89) ABCB1PPIAFKBP1BABCC1ABCC2
SCHEMBL19646863 1.00 ABCB1 (0.89) ABCB1PPIAFKBP1BABCC1ABCC2
SCHEMBL16596082 1.00 ABCB1 (0.89) ABCB1PPIAFKBP1BABCC1ABCC2
SCHEMBL1708943 0.98 ABCB1 (0.89) ABCB1PPIAFKBP1BABCC1ABCC2
SCHEMBL101371 0.98 ABCB1 (0.89) ABCB1PPIAFKBP1BABCC1ABCC2
SCHEMBL18163232 0.98 ABCB1 (0.89) ABCB1PPIAFKBP1BABCC1ABCC2
SCHEMBL439348 0.96 ABCB1 (0.89) ABCB1PPIAFKBP1BABCC1ABCC2
SCHEMBL22032784 0.96 ABCB1 (0.89) ABCB1PPIAFKBP1BABCC1ABCC2
Cyclosporine SCHEMBL25083206 0.94 ABCB1 (1.00) ABCB1PPIAFKBP1BABCC1ABCC2
Cyclosporine SCHEMBL24239446 0.94 ABCB1 (1.00) ABCB1PPIAFKBP1BABCC1ABCC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 502 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115266996-B Analysis method and application of related substances in cyclosporine A preparation 兆科(广州)眼科药物有限公司 2024-04-30 CN claimed
CN-115803063-A Nanolipid protein-polypeptide conjugates and compositions, systems, and methods of use thereof 基因泰克公司 2023-03-14 CN claimed
CN-115266996-A Analysis method and application of related substances in cyclosporin A preparation 兆科(广州)眼科药物有限公司 2022-11-01 CN claimed
EP-2931299-B1 NOVEL PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF PERIODONTAL DISEASE PERIOC LTD (GB) 2019-02-06 EP claimed
US-20160304554-A1 PROCESS FOR THE MANUFACTURE OF CYCLIC UNDECAPEPTIDES NOVARTIS PHARMA AG (CH) 2016-10-20 US claimed
WO-2015193673-A1 NOVEL PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF PERIODONTAL DISEASE PERIOC LIMITED (GB) 2015-12-23 WO claimed
US-20150313959-A1 NOVEL PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF PERIODONTAL DISEASE PERIOC LTD (GB) 2015-11-05 US claimed
EP-2931299-A1 NOVEL PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF PERIODONTAL DISEASE Perioc Ltd. (GB) 2015-10-21 EP claimed
US-20150087808-A1 PROCESS FOR THE MANUFACTURE OF CYCLIC UNDECAPEPTIDES NOVARTIS AG (CH) 2015-03-26 US claimed
WO-2014091239-A1 NOVEL PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF PERIODONTAL DISEASE PERIOC LTD (GB) 2014-06-19 WO claimed
WO-1997018828-A1 INHIBITORS OF CYCLOPHILIN ROTAMASE ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 1997-05-29 WO claimed
US-5616595-A CONCENTRATION, SOLUBILIZING, DIAFILTRATION IN A CLOSED RECIRCULATION SYSTEM ABBOTT LABORATORIES (US) 1997-04-01 US claimed
WO-1996040089-A2 AEROSOL DRUG FORMULATIONS CONTAINING VEGETABLE OILS ABBOTT LABORATORIES (US) 1996-12-19 WO claimed
WO-1996040758-A1 PROCESS FOR RECOVERING WATER-INSOLUBLE COMPOUNDS FROM A FERMENTATION BROTH ABBOTT LABORATORIES (US) 1996-12-19 WO claimed
US-5382655-A Process for the purification of cyclosporin A BIOGAL GYOGYSZERARUGYAR RT (HU) 1995-01-17 US claimed
EP-0379708-B1 Fungi strain Tolypocladiam varium and process for obtaining complexes of antibiotic cyclosporin and/or its components BIOGAL GYOGYSZERGYAR (HU) 1994-12-07 EP claimed
US-5051402-A Fungicides, immunosuppressants and antiphlogistic agents SANKYO COMPANY, LIMITED (JP) 1991-09-24 US claimed
EP-0379708-A1 Fungi strain Tolypocladiam varium and process for obtaining complexes of antibiotic cyclosporin and/or its components BIOGAL GYOGYSZERGYAR (HU) 1990-08-01 EP claimed
WO-1990000389-A1 FREEZE-DRIED LIPOSOME COMPOSITIONS CONTAINING CYCLOSPORIN REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 1990-01-25 WO claimed
US-4727035-A RADIOACTIVE OR FLUORESCENT LABELS SANDOZ LTD. (CH) 1988-02-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150313959-A1 NOVEL PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF PERIODONTAL DISEASE PPIL1, PPIG, PPID ABCB1 158/4885PPIA 12/4885FKBP1B 19/4885
US-20150087808-A1 PROCESS FOR THE MANUFACTURE OF CYCLIC UNDECAPEPTIDES UMPS, SAMHD1, NPEPPS ABCB1 1583/4885PPIA 951/4885FKBP1B 1288/4885
US-20160304554-A1 PROCESS FOR THE MANUFACTURE OF CYCLIC UNDECAPEPTIDES UMPS, SAMHD1, NPEPPS ABCB1 1583/4885PPIA 951/4885FKBP1B 1288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.